Medindia
Medindia LOGIN REGISTER
Advertisement

Pixelgen Technologies Announces Upcoming Participation at American Society of Hematology Annual Meeting

Thursday, December 5, 2024 Press Release
Advertisement
PR Newswire

STOCKHOLM, Dec. 5, 2024

STOCKHOLM, Dec. 5, 2024 /PRNewswire/ -- Pixelgen Technologies, a leader in cell surface proteomics for single cells, today announced upcoming participation at the 66th American Society of Hematology Annual Meeting and Exposition (ASH) in San Diego, Calif. from Dec. 7-10 at the San Diego Convention Center. New data from collaborators will support the application of Pixelgen's patented Molecular Pixelation (MPX) technology and kit across a broad range of scientific research, as the company expands into hematology.
Advertisement



"With spatial mapping of cell surface proteins, hematology researchers can gain unprecedented insights into the organization and function of protein and protein complexes critical to blood cell function and disease," said Pixelgen CEO Simon Fredriksson, Ph.D. "This capability promises to advance diagnostics, enable personalized therapeutics, and support the development of next-generation treatments for blood cancers, immune dysregulation, and hematopoietic disorders. We're excited to be participating in ASH for the first time and sharing our groundbreaking technology with the hematology community."
Advertisement

Pixelgen will be featured in two sessions:

Pixelgen will be at Booth #2852 showcasing its product and technology. Representatives will be available to discuss the company's latest data on identifying CAR-T cells and mapping their cell surface proteome for detailed mechanism of action studies. To support the company's work in hematology, Pixelgen has developed an Application Note, in collaboration with Illumina, looking at cancer specific protein patterns of blood cancer cells, which is available here.

About Pixelgen TechnologiesPixelgen Technologies AB was founded in 2020 by a team of passionate, experienced innovators and entrepreneurs with a vision to bring a new spatial understanding to biology by mapping cell surface proteins and their spatial inter-relationships. The company has developed Molecular Pixelation, a DNA-based visualization technology for analyzing cell surface proteins, to gain novel insights into cellular activity that will advance better medicines and diagnostics. Pixelgen is headquartered in Stockholm, Sweden.

Contacts

Corporate:Annika [email protected]+46 762-69 68 46

Media:Susan [email protected]+1 (619) 540-9195

View original content to download multimedia:https://www.prnewswire.com/news-releases/pixelgen-technologies-announces-upcoming-participation-at-american-society-of-hematology-annual-meeting-302323258.html

SOURCE Pixelgen Technologies
Sponsored Post and Backlink Submission


This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close